Baxter Raises 2026 Sales and EPS Guidance, Retires $864 Million Debt
Baxter raised its full-year reported sales growth outlook to 4%–5% from 3%–4% and lifted the lower end of adjusted diluted EPS guidance to $2.05 from $1.95, maintaining the $2.15 upper end. It also completed a $600 million cash tender offer, retiring $864 million in debt.
Baxter International has increased its full-year 2026 reported sales growth guidance to a range of 4% to 5%, up from the previous 3% to 4%. The company also raised the lower end of its adjusted diluted EPS guidance to $2.05 from $1.95, while maintaining the upper end at $2.15. In addition to these financial updates, Baxter completed a $600 million cash tender offer during the quarter, which resulted in the retirement of $864 million in debt. These actions are part of the company's broader strategy to strengthen its balance sheet.
The updates follow the company's third-quarter 2026 results, which showed year-over-year sales growth of 5% to $2.98 billion.